ctrl K

Price Alert

Xeris Biopharma Inc. (XERS)

NASDAQ: XERS · Real-Time Price · USD

7.66

0.36 (4.93%)

At close: Aug 15, 2025, 3:59 PM

7.67

0.13%

After-hours: Aug 15, 2025, 07:25 PM EDT

Xeris Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	71.62M	67.45M	121.97M	121.97M
Short-Term Investments	n/a	5M	n/a	35.16M
Long-Term Investments	n/a	n/a	4.35M	-364K
Other Long-Term Assets	1.28M	4.54M	267K	4.73M
Receivables	40.41M	39.2M	30.83M	17.46M
Inventory	48.17M	38.84M	24.73M	24.73M
Other Current Assets	7.45M	5.78M	9.29M	n/a
Total Current Assets	167.66M	156.26M	186.82M	186.82M
Property-Plant & Equipment	28.21M	29.18M	28.38M	28.38M
Goodwill & Intangibles	121.78M	132.62M	124.6M	124.6M
Total Long-Term Assets	161.49M	166.34M	157.7M	157.7M
Total Assets	323.06M	322.6M	344.52M	344.52M
Account Payables	2.29M	11.56M	4.61M	8.92M
Deferred Revenue	n/a	n/a	64.78M	n/a
Short-Term Debt	15.1M	n/a	1.58M	n/a
Other Current Liabilities	39.75M	51.43M	25.65M	18.95M
Total Current Liabilities	100.44M	95.19M	73.62M	73.62M
Long-Term Debt	217.01M	190.93M	187.07M	88.07M
Other Long-Term Liabilities	1.97M	6.23M	25.72M	37.08M
Total Long-Term Liabilities	252.23M	234.19M	225.71M	225.71M
Total Liabilities	352.68M	329.38M	299.33M	299.33M
Total Debt	271.45M	229.19M	198.06M	198.06M
Common Stock	15K	14K	14K	14K
Retained Earnings	-671.86M	-617.02M	-554.77M	-554.77M
Comprehensive Income	-25K	-25K	-23K	-23K
Shareholders Equity	-29.61M	-6.78M	45.19M	45.19M
Total Investments	n/a	5M	4.35M	35.16M